Literature DB >> 21960548

Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.

Kymberly M Gowdy1, Julia L Nugent, Tereza Martinu, Erin Potts, Laurie D Snyder, W Michael Foster, Scott M Palmer.   

Abstract

T-box expressed in T cells (T-bet) is a critical transcription factor for T helper (Th) 1 responses. Although Th1 cells are thought to contribute to certain alloimmune responses, their role in pulmonary graft-versus-host disease (GVHD) is uncertain. We have established a murine model of acute pulmonary GVHD after hematopoietic cell transplant (HCT) and inhaled LPS exposure. We tested the hypothesis that pulmonary GVHD can occur independent of Th1 cells using T-bet-deficient donors. B10.BR(H2(k)) mice underwent allogeneic (Allo) or syngeneic (Syn) HCT with cells from either C57Bl/6J(H2(b)) mice (Allo wild-type [WT] or SynWT) or C57Bl/6J mice lacking T-bet (AlloTbet(-/-) or SynTbet(-/-)). After HCT, mice were exposed daily to aerosolized LPS and subsequently bronchoalveolar lavage and lung tissue were analyzed for cytokines, lymphocytic inflammation, pathology, and fibrosis. Independent of LPS exposure, AlloTbet(-/-) mice developed pulmonary GVHD manifested by lymphocytic inflammation. Furthermore, AlloTbet(-/-) mice developed features of chronic pulmonary GVHD, including increased peribronchiolar fibrosis and collagen content. LPS exposure increased neutrophil recruitment and decreased static compliance in AlloTbet(-/-) mice as compared with LPS-exposed AlloWT mice or LPS-exposed SynTbet(-/-) mice. In addition, LPS-exposed AlloTbet(-/-) mice had increased pulmonary IL-17, IL-13, and Th17 cells, and diminished regulatory T cells compared with the other groups. Our results demonstrate that Th1 cytokines are dispensable in pulmonary GVHD. In the absence of T-bet, there is increased production of Th17 and Th2 cytokines that is associated with peribronchiolar fibrosis and is further enhanced by LPS. These results suggest that the interplay between local innate immunity and non-Th1 T cell subsets contribute to chronic pulmonary GVHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960548      PMCID: PMC3297167          DOI: 10.1165/rcmb.2011-0131OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  51 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

Authors:  Bryon D Johnson; Marja C Konkol; Robert L Truitt
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

3.  Allogeneic stem cell transplant, lung disease, and airflow obstruction.

Authors:  Rodney J Folz
Journal:  Am J Respir Crit Care Med       Date:  2003-07-15       Impact factor: 21.405

4.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

Review 5.  Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation.

Authors:  Jean E Sanders
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

7.  Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.

Authors:  Emiko Sakaida; Chiaki Nakaseko; Akane Harima; Akira Yokota; Ryuko Cho; Yasushi Saito; Miki Nishimura
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

8.  Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

Authors:  C G Lee; R J Homer; Z Zhu; S Lanone; X Wang; V Koteliansky; J M Shipley; P Gotwals; P Noble; Q Chen; R M Senior; J A Elias
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

9.  Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Petra Hoffmann; Joerg Ermann; Matthias Edinger; C Garrison Fathman; Samuel Strober
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

10.  CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Authors:  José L Cohen; Aurélie Trenado; Douglas Vasey; David Klatzmann; Benoît L Salomon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  12 in total

Review 1.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

Review 2.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Authors:  Casey T Weaver; Charles O Elson; Lynette A Fouser; Jay K Kolls
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

Review 3.  Cytokine mediators of chronic graft-versus-host disease.

Authors:  Kelli Pa MacDonald; Bruce R Blazar; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

4.  T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.

Authors:  Jianing Fu; Dapeng Wang; Yu Yu; Jessica Heinrichs; Yongxia Wu; Steven Schutt; Kane Kaosaard; Chen Liu; Kelley Haarberg; David Bastian; Daniel G McDonald; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

5.  The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells.

Authors:  John S Thompson; Debra L Hardin; Judy F Glass; Joshua Dziba; Jeffrey Campion; Stephen A Brown
Journal:  SOJ Immunol       Date:  2016

6.  Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.

Authors:  Kymberly M Gowdy; Tereza Martinu; Julia L Nugent; Nicholas D Manzo; Helen L Zhang; Francine L Kelly; Michael J Holtzman; Scott M Palmer
Journal:  Transpl Immunol       Date:  2014-11-05       Impact factor: 1.708

7.  SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

Authors:  Jonathan C Poe; Wei Jia; Julie A Di Paolo; Nancy J Reyes; Ji Yun Kim; Hsuan Su; John S Sundy; Adela R Cardones; Victor L Perez; Benny J Chen; Nelson J Chao; Diana M Cardona; Daniel R Saban; Stefanie Sarantopoulos
Journal:  JCI Insight       Date:  2018-10-04

Review 8.  The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.

Authors:  Elizabeth A Lendermon; Jeffrey M Dodd-o; Tiffany A Coon; Hannah L Miller; Sudipto Ganguly; Iulia Popescu; Christopher P O'Donnell; Nayra Cardenes; Melanie Levine; Mauricio Rojas; Nathaniel M Weathington; Jing Zhao; Yutong Zhao; John F McDyer
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

10.  Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.

Authors:  Vanaja Konduri; Matthew M Halpert; Dan Liang; Jonathan M Levitt; Julio Vladimir Cruz-Chan; Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Kathryn M Jones; William K Decker
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.